Alissa Cooper, MD

Alissa Cooper, MD, earned her medical degree from Brown University, trained in residency at Brigham and Women’s Hospital, and completed a hematology/oncology fellowship at Dana-Farber/Mass General Brigham. She previously served on the Thoracic Oncology and Early Drug Development Services at Memorial Sloan Kettering. Dr. Cooper leads clinical trials of novel therapies for thoracic and high-grade neuroendocrine cancers and is dedicated to personalized patient care and advancing research to improve outcomes.